Anti-CD22-NMS249 Preis auf Anfrage

Artikelnummer: TGM-T9901A-233
Artikelname: Anti-CD22-NMS249 Preis auf Anfrage
Artikelnummer: TGM-T9901A-233
Hersteller Artikelnummer: T9901A-233
Alternativnummer: TGM-T9901A-233-1MG,TGM-T9901A-233-5MG
Hersteller: TargetMol
Kategorie: Biochemikalien
Anti-CD22-NMS249 is an antibody-drug conjugate (ADC) that targets CD22, comprising the humanized anti-CD22 antibody Pinatuzumab, a cleavable linker (Mc-VC-PAB), and the effective payload of DNA topoisomerase II inhibitor PNU-159682. This compound is utilized in the study of non-Hodgkin lymphoma (NHL).
Molekulargewicht: 818.91
Formel: C41H45F3N8O5S
Target-Kategorie: Antibody-Drug Conjugates (ADCs)
T9901A-233